Stocks Health care AVCRF
OTC · Health careAvricore Health Inc. (AVCRF)
Avricore Health Inc. reported revenue of CA$4.7M in fiscal 2024, up 33.7% from a year earlier. It posted a net loss of CA$669K. Operating cash flow minus capital spending left CA$823.5K of free cash flow in fiscal 2024. At December 31, 2024 it held CA$1.1M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on June 16, 2025.
Watch AVCRF in 60 secondsWhat Avricore Health Inc. does
Avricore Health Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker AVCRF.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2024 | CA$4.7M | -CA$669K | -CA$0.01 | CA$823.5K |
| 2023 | CA$3.5M | -CA$701.2K | -CA$0.01 | -CA$361.2K |
| 2022 | CA$1.8M | -CA$818.2K | -CA$0.01 | -CA$1.6M |
| 2021 | CA$122.8K | -CA$1.7M | -CA$0.02 | -CA$1.3M |
| 2020 | CA$33K | -CA$1.2M | -CA$0.02 | n/a |
| 2019 | n/a | -CA$1.9M | -CA$0.04 | n/a |
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Avricore Health Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 17, 2026
- July 13, 2026
- June 11, 2026
- May 11, 2026
- February 17, 2026
- January 12, 2026
- December 10, 2025
- September 15, 2025
- August 8, 2025
- July 11, 2025
Questions about AVCRF
What does Avricore Health Inc. do?
Avricore Health Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker AVCRF.
Is Avricore Health Inc. profitable?
No. In fiscal 2024 it reported a net loss of CA$669K on revenue of CA$4.7M.
How much revenue does Avricore Health Inc. make?
In fiscal 2024 Avricore Health Inc. reported revenue of CA$4.7M. That is 33.7% more than a year earlier.
When did Avricore Health Inc. last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on June 16, 2025. It covers the period to December 31, 2024. Its newest filing of any kind is the foreign issuer update from September 17, 2026.
Similar companies
Compare AVCRF with
Compare AVCRF with any company
Follow AVCRF
Get an email when Avricore Health Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow AVCRF: get an email when it filesWhere the numbers come from
Financial figures are the values Avricore Health Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.